Kesselheim AS - Search Results

1

Teng TW, Kesselheim AS, Tu SS. Teng TW, et al. Among authors: kesselheim as. IEEE Pulse. 2022 Sep-Oct;13(5):33-37. doi: 10.1109/MPULS.2022.3209128. IEEE Pulse. 2022. PMID: 36301809

2

Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings.

Egilman AC, Van de Wiele VL, Rome BN, Darrow JJ, Tu SS, Kesselheim AS, Sarpatwari A. Egilman AC, et al. Among authors: kesselheim as. JAMA Intern Med. 2023 Jan 1;183(1):82-84. doi: 10.1001/jamainternmed.2022.5419. JAMA Intern Med. 2023. PMID: 36441536 Free PMC article.

3

Recent Patent Reform Bills and Their Implications for Prescription Drugs.

Tu SS, Nagar S, Kesselheim AS. Tu SS, et al. Among authors: kesselheim as. JAMA. 2023 Feb 14;329(6):459-460. doi: 10.1001/jama.2022.24983. JAMA. 2023. PMID: 36637860

4

Patenting Strategies on Inhaler Delivery Devices.

Demkowicz BJ, Tu SS, Kesselheim AS, Carrier MA, Feldman WB. Demkowicz BJ, et al. Among authors: kesselheim as. Chest. 2023 Aug;164(2):450-460. doi: 10.1016/j.chest.2023.02.031. Epub 2023 Feb 25. Chest. 2023. PMID: 36842533

5

Patent Challenges And Litigation On Inhalers For Asthma And COPD.

Reddy S, Beall RF, Tu SS, Kesselheim AS, Feldman WB. Reddy S, et al. Among authors: kesselheim as. Health Aff (Millwood). 2023 Mar;42(3):398-406. doi: 10.1377/hlthaff.2022.00873. Health Aff (Millwood). 2023. PMID: 36877911

6

Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.

Alhiary R, Kesselheim AS, Gabriele S, Beall RF, Tu SS, Feldman WB. Alhiary R, et al. Among authors: kesselheim as. JAMA. 2023 Aug 15;330(7):650-657. doi: 10.1001/jama.2023.13872. JAMA. 2023. PMID: 37505513

7

Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition.

Sarpatwari A, Kohli S, Tu SS, Kesselheim AS. Sarpatwari A, et al. Among authors: kesselheim as. JAMA. 2024 Mar 19;331(11):976-978. doi: 10.1001/jama.2024.0924. JAMA. 2024. PMID: 38386345

8

Federal Trade Commission Actions on Prescription Drugs, 2000-2022.

Daval CJR, Egilman AC, Sarpatwari A, Kesselheim AS. Daval CJR, et al. Among authors: kesselheim as. JAMA. 2024 May 20. doi: 10.1001/jama.2024.5737. Online ahead of print. JAMA. 2024. PMID: 38767878

9

Trust in the Food and Drug Administration: A National Survey Study.

Feldman WB, Rand LZ, Carpenter D, Russo M, Bhaskar A, Lu Z, Campbell EG, Darrow J, Kesselheim AS. Feldman WB, et al. Among authors: kesselheim as. Clin Pharmacol Ther. 2024 May 16. doi: 10.1002/cpt.3292. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38757305

10

Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020.

Mahesri M, Sarpatwari A, Huybrechts KF, Lii J, Lee SB, Toyserkani GA, LaCivita C, Zhou EH, Pan GJD, Kesselheim AS, Bykov K. Mahesri M, et al. Among authors: kesselheim as. Drug Saf. 2024 May 16. doi: 10.1007/s40264-024-01443-3. Online ahead of print. Drug Saf. 2024. PMID: 38755509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

712 results

Search Page